RxDoctor Payments Data

Stephanie Mackey, MD

Dermatology · Lancaster, PANPI 1205834249

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $86,875 of the $103,655 with a category attached, or 83.8%. AbbVie accounts for 64.5% of it on its own, with 27 other manufacturers making up the rest. Reporting peaked in 2019 at $43,471 and has fallen 92.8% since, to $3,117 in 2025. Among dermatology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$103,655in general payments, 2019–2025

Across 716 payments — averaging $144.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$67K
  • Pfizer$29K
  • Sun Pharmaceutical Industries Inc.$1K
  • Novartis$905
  • Johnson & Johnson$808
  • Galderma Laboratories, L.p.$691
  • plus $4K from 22 others

What the payments were for

  • Speaking & faculty fees$86,87584%
  • Travel & lodging$3,0853%
  • Food & beverage$13,48713%
  • Education$2070%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$103,655 in reported general payments places this provider in the 95th percentile of 626 dermatology providers in Pennsylvania.

See all dermatology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$108,673
Medicare patients
300
Services billed
1,430

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Calcipotriene36$5,967
Tacrolimus31$5,610
Clindamycin Phosphate29$1,415
Clobetasol Propionate40$1,215
Ketoconazole53$1,051
Betamethasone Dipropionate21$929
Fluocinonide20$815
Metronidazole15$714
Minocycline Hcl24$507
Doxycycline Hyclate16$346
Ammonium Lactate11$304
Spironolactone14$177
Triamcinolone Acetonide38$154
Cephalexin18$139
Hydrocortisone13$67

Paid to pharmacies, not to this prescriber.

Other dermatology in Lancaster

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →